MedPage Today on MSN
Chemo-Free Regimen for Endometrial Cancer Produces Durable Responses, Favorable PFS
More than half of patients with recurrent/advanced disease were progression-free at 6 mont ...
Palazestrant’s mechanism of action confirmed; full recruitment of corepressor protein NCoR1 enables complete antagonism of the estrogen ...
As we age, our ability to maintain healthy blood and a strong immune system gradually declines, largely because hematopoietic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results